Oxford Biomedica shares were up 3% to 468p in late morning trading on Friday after the firm announced it had entered into a three-year Master Services and Development Agreement with AstraZeneca. The Agreement would reportedly facilitate the potential future manufacturing opportunities for the AstraZeneca Covid-19 vaccine. Oxford Biomedica noted the deal represents an expansion of […]

The post Oxford BioMedica agrees 3-year extension to AstraZeneca Covid-19 vaccine deal appeared first on UK Investor Magazine.

Total UK deaths linked to virus now at 128,222 Boris Johnson will on Monday at 5pm announce the beginning of the end of strict Covid-19 measures as of July 19, according to Sky News. This includes, among other things, the requirement to wear face masks, social distancing and the guidance to work from home where […]

The post Johnson to tell Brits to ‘learn to live’ with virus ahead of further easing of restrictions appeared first on UK Investor Magazine.

Under-30s make up the final group on the priority list People in England who are older than 25 years of age are now being called to receive the Covid-19 vaccine from tomorrow, confirmed UK health secretary Matt Hancock. Hancock’s announcement signals the final stage of the vaccination programme which began in December 2020. Under-30s make […]

The post Covid-19 vaccine now available for those aged over 25 appeared first on UK Investor Magazine.

As the mass Covid-19 vaccination drive continues, new data from Finaria.it has revealed that vaccine developers BioNTech-Pfizer (NASDAQ:BNTX, NYSE:PFE) and Moderna (NASDAQ:MRNA) are set to bank $14.7bn in revenue from sales of their coronavirus vaccines by 2023. The Pfizer-BioNTech candidate made headlines for becoming the first vaccine to be approved for use in the general […]

The post Vaccine developers to bank $14.7bn by 2023 appeared first on UK Investor Magazine.

Shares at American pharmaceutical firm Pfizer (NYSE:PFE) have slipped after its announcement that it will be temporary reducing deliveries of its Covid-19 vaccine to Europe while it seeks to upgrade its production capacity to the target 2 billion doses per year. “This temporary reduction will affect all European countries,” a spokeswoman for Pfizer Denmark said […]

The post Pfizer shares slide on vaccine delivery cuts appeared first on UK Investor Magazine.

Shares at British biotechnology firm Synairgen (LON:SNG) have surged more than 7% after the launch of its new large-scale Covid-19 treatment trial. The Southampton-based company treated its first patient at Hull Royal Infirmary on Tuesday afternoon, using the newly-developed formulation SNG001, which involves the inhalation of a naturally-occurring protein named interferon beta which is believed […]

The post Synairgen shares surge on trial launch appeared first on UK Investor Magazine.

Vaccines are increasingly being seen as the key to a sustained recovery for UK businesses. New research has revealed that 92% of owners of independent public-facing companies across the retail, hospitality and travel sectors believe that vaccinating British consumers is the “golden ticket” to a post-pandemic recovery, and are reportedly considering inviting back the customers […]

The post 92% of businesses say vaccines are “golden ticket” to recovery appeared first on UK Investor Magazine.

A new study commissioned by trading broker HYCM has revealed how anxieties surrounding the coronavirus pandemic and Brexit has affected UK investors’ plans for 2021, with the majority believing the true impact on the UK economy will not be seen until next year. The survey was conducted across 885 UK-based investors, all of whom have […]

The post Investors predict worse Covid fallout in 2021 appeared first on UK Investor Magazine.

US biotech firm Moderna (NASDAQ:MRNA) announced on Monday that its vaccine candidate has an efficacy rate of 94.5%. Similarly, Belgian company Janssen, a subsidiary of Johnson & Johnson (NYSE:JNJ), announced that it would begin its phase three UK trials on Monday. “It is really important we pursue many different vaccines from many different manufactures,” said […]

The post Moderna vaccine and Janssen trial lift stocks hardest-hit by COVID appeared first on UK Investor Magazine.